L’IMC générique non invasif qui sera utilisé dans la neuroréadaptation de multiples troubles neurologiques au Centre de neuroréadaptation San Raffaele du Neurotech Hub. (IMAGE)

Associação Alberto Santos Dumont para Apoio à Pesquisa

L’IMC générique non invasif qui sera utilisé dans la neuroréadaptation de multiples troubles neurologiques au Centre de neuroréadaptation San Raffaele du Neurotech Hub.

Caption

Figure 1 – L’IMC générique non invasif conçu par le Dr Nicolelis et son équipe de recherche qui sera utilisé dans la neuroréadaptation de multiples troubles neurologiques au Centre de neuroréadaptation San Raffaele du Neurotech Hub.

Credit

Nicolelis Institute for Advanced Brain Studies

Usage Restrictions

Only noncommercial uses of the work are permitted. News organizations may use or redistribute this image, with proper attribution, as part of news coverage of this paper only. No derivatives or adaptations of the work are permitted.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.